Secukinumab in plaque psoriasis - Results of two phase 3 trials

Richard G. Langley; Boni E. Elewski; Mark Lebwohl; Kristian Reich; Christopher E.M. Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárour Sigurgeirsson; Enrique Rivas; Tsen Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis

doi:10.1056/NEJMoa1314258

Secukinumab in plaque psoriasis - Results of two phase 3 trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl, Kristian Reich, Christopher E.M. Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárour Sigurgeirsson, Enrique Rivas, Tsen Fang Tsai, Norman Wasel, Stephen Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, Charis Papavassilis

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

1697 Citations (Scopus)

Original language	English
Pages (from-to)	326-338
Number of pages	13
Journal	New England Journal of Medicine
Volume	371
Issue number	4
DOIs	https://doi.org/10.1056/NEJMoa1314258
Publication status	Published - 2014

ASJC Scopus Subject Areas

General Medicine

Access to Document

10.1056/NEJMoa1314258

Cite this

Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., Rivas, E., Tsai, T. F., Wasel, N., Tyring, S., Salko, T., Hampele, I., Notter, M., Karpov, A., Helou, S., & Papavassilis, C. (2014). Secukinumab in plaque psoriasis - Results of two phase 3 trials. New England Journal of Medicine, 371(4), 326-338. https://doi.org/10.1056/NEJMoa1314258

Langley, RG, Elewski, BE, Lebwohl, M, Reich, K, Griffiths, CEM, Papp, K, Puig, L, Nakagawa, H, Spelman, L, Sigurgeirsson, B, Rivas, E, Tsai, TF, Wasel, N, Tyring, S, Salko, T, Hampele, I, Notter, M, Karpov, A, Helou, S & Papavassilis, C 2014, 'Secukinumab in plaque psoriasis - Results of two phase 3 trials', New England Journal of Medicine, vol. 371, no. 4, pp. 326-338. https://doi.org/10.1056/NEJMoa1314258

@article{175152e73ca54e1a91d7f4389f8b37e4,

title = "Secukinumab in plaque psoriasis - Results of two phase 3 trials",

author = "Langley, {Richard G.} and Elewski, {Boni E.} and Mark Lebwohl and Kristian Reich and Griffiths, {Christopher E.M.} and Kim Papp and Llu{\'i}s Puig and Hidemi Nakagawa and Lynda Spelman and B{\'a}rour Sigurgeirsson and Enrique Rivas and Tsai, {Tsen Fang} and Norman Wasel and Stephen Tyring and Thomas Salko and Isabelle Hampele and Marianne Notter and Alexander Karpov and Silvia Helou and Charis Papavassilis",

year = "2014",

doi = "10.1056/NEJMoa1314258",

language = "English",

volume = "371",

pages = "326--338",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Secukinumab in plaque psoriasis - Results of two phase 3 trials

AU - Langley, Richard G.

AU - Elewski, Boni E.

AU - Lebwohl, Mark

AU - Reich, Kristian

AU - Griffiths, Christopher E.M.

AU - Papp, Kim

AU - Puig, Lluís

AU - Nakagawa, Hidemi

AU - Spelman, Lynda

AU - Sigurgeirsson, Bárour

AU - Rivas, Enrique

AU - Tsai, Tsen Fang

AU - Wasel, Norman

AU - Tyring, Stephen

AU - Salko, Thomas

AU - Hampele, Isabelle

AU - Notter, Marianne

AU - Karpov, Alexander

AU - Helou, Silvia

AU - Papavassilis, Charis

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904545875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904545875&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa1314258

DO - 10.1056/NEJMoa1314258

M3 - Article

C2 - 25007392

AN - SCOPUS:84904545875

SN - 0028-4793

VL - 371

SP - 326

EP - 338

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -

Secukinumab in plaque psoriasis - Results of two phase 3 trials

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this